Case report: Satralizumab therapy for bilateral refractory optic neuritis following the first dose of bivalent human papilloma virus vaccine
Demyelinating optic neuritis (DON) is a rare but sight-threatening ophthalmic condition which occasionally occurs after human papilloma virus (HPV) vaccination. We herein report a case of previously healthy 13-year-old girl who developed a bilateral refractory DON three days after the first dose of...
        Saved in:
      
    
          | Main Author: | Chuanbin Sun | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Frontiers Media S.A.
    
        2024-11-01 | 
| Series: | Frontiers in Immunology | 
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1499045/full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case        
                          
 by: Chuanbin Sun, et al.
 Published: (2024-12-01)
- 
                
                    Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G–seropositive neuromyelitis optica spectrum disorder: a case series report        
                          
 by: Hesham Abboud, et al.
 Published: (2025-01-01)
- 
                
                    Pediatric optic neuritis        
                          
 by: Juan Manuel Pardo-Muñoz
 Published: (2019-01-01)
- 
                
                    Optic neuritis        
                          
 by: J. Katelytė, et al.
 Published: (2019-06-01)
- 
                
                    The imprint of viral oncoproteins on the variable clinical behavior among human papilloma virus-related oropharyngeal squamous cell carcinomas        
                          
 by: Malay K. Sannigrahi, et al.
 Published: (2024-12-01)
 
       